25 ago
|
Institut de Recerca contra la Leucèmia Josep Carreras
|
España
25 ago
Institut de Recerca contra la Leucèmia Josep Carreras
España
The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced an exponential growth.
The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC) Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII) .
The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions,
providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has six locations integrated into reference hospitals : Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Josep Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.
We are looking for an experienced Postdoctoral Researcher to join a multidisciplinary team led by Dr. Marcus Buschbeck at IJC’s headquarters.
RESEARCH DESCRIPTION
Histone variants replace replication-coupled histones within nucleosomes, the fundamental units of chromatin, and confer specialized properties to specific genomic regions. The macroH2A family is of particular interest because th
📌 VAC_70_2026 - POSTDOCTORAL RESEARCHER (España)
🏢 Institut de Recerca contra la Leucèmia Josep Carreras
📍 España